Nortian

About Nortian

Nortian is a biotech company focused on transforming meat byproducts, which are often discarded, into high-value, food-grade ingredients. Founded in 2024 by Andre Albuquerque, the company pioneers the production of ultra-pure collagen through a proprietary, vertically integrated process. Albuquerque has over a decade of experience in the food, supplements, and ingredients sectors, having previously built and sold one of Latin America's largest supplement contract manufacturing companies. Nortian's process yields collagen with 99% purity and 98% protein concentration, among the highest in the global market.

The company's business model is centered on sustainability and circular economy practices, aiming to bridge industrial food systems with modern biotechnology. In May 2025, Nortian announced it had raised $41 million in a funding round, achieving a post-money valuation of $100 million. This financing is dedicated to launching its U.S. manufacturing operations in St. Joseph, Missouri. The new state-of-the-art facility will span over 90,000 square feet with an initial production capacity of 600 tons per month, with plans to scale to 1,000 tons. The $22.2 million project is expected to create 138 new jobs in the region. Nortian serves the wellness, food, and pharmaceutical industries, which are driving a global collagen market projected to nearly double to almost $20 billion by 2030.